Early Retirement Portfolio: Top 15 Stock Picks

Page 11 of 15

5. Abbott Laboratories (NYSE:ABT)

Dividend Yield: 1.77%

Number of Hedge Fund Holders: 70

Abbott Laboratories (NYSE:ABT) ranks among the top stocks for an early retirement portfolio. On June 18, Oppenheimer reaffirmed its $140 price target and Outperform rating on Abbott Laboratories (NYSE:ABT), noting growing confidence in the company’s Volt system and future glucose-ketone monitoring technology.

Following the observation of live PFA (pulsed field ablation) case viewings of rival systems, such as Varipulse/CARTO and Farapulse/Opal, the research firm voiced increasing optimism concerning Volt. Varipulse’s uptake has been “subdued” despite price parity with Farapulse, according to Oppenheimer.

Oppenheimer found two significant catalysts for Abbott Laboratories (NYSE:ABT) that might boost the company’s performance in the second half of 2025. First, if Abbott leverages cost as a competitive advantage, the possible approval of Volt PMA might result in “significant gains” in electrophysiology.

The second driver is Abbott’s glucose-ketone dual sensor system, which was recently revealed to be integrated with the insulin pump from Tandem Diabetes Care.

Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items.

Page 11 of 15